Showing results (51-60 of 259) with videos related to
Sort By:
Pageof 26
Antibiotics (Basel, Switzerland)|February 27, 2020
Critical Parameters for the Development of Novel Therapies for Severe and Resistant Infections-A Case Study on CAL02, a Non-Traditional Broad-Spectrum Anti-Virulence DrugSamareh Azeredo da Silveira, Andrew F ShorrThe Journal of Antimicrobial Chemotherapy|December 15, 2010
Outcomes with micafungin in patients with candidaemia or invasive candidiasis due to Candida glabrata and Candida kruseiAndrew F Shorr, Chunzhang Wu, Smita KothariPathogens (Basel, Switzerland)|June 26, 2024
Improving Outcomes in Nosocomial Pneumonia: Recent Evidence and More ChallengesIhab H Masri, Bethany Busack, Andrew F ShorrCurrent Opinion in Infectious Diseases|October 7, 2022
Novel agents in development for multidrug-resistant Gram-negative infections: potential new options facing multiple challengesRadhika Arya, Breanna S Goldner, Andrew F ShorrBiomedicines|March 28, 2024
At the Intersection of Critical Care and Infectious Diseases: The Year in ReviewSarah R Sabo, Aarthi Venkatramanan, Andrew F ShorrCritical Care (London, England)|June 24, 2009
Cost-effectiveness of micafungin as an alternative to fluconazole empiric treatment of suspected ICU-acquired candidemia among patients with sepsis: a model simulationMarya D Zilberberg, Smita Kothari, Andrew F ShorrInfection Control and Hospital Epidemiology|June 23, 2009
Cost-effectiveness analysis of a silver-coated endotracheal tube to reduce the incidence of ventilator-associated pneumoniaAndrew F Shorr, Marya D Zilberberg, Marin KollefThe Journal of Antimicrobial Chemotherapy|October 1, 2005
Linezolid versus vancomycin for Staphylococcus aureus bacteraemia: pooled analysis of randomized studiesAndrew F Shorr, Mark J Kunkel, Marin KollefViruses|August 26, 2023
Respiratory Viruses in Nosocomial Pneumonia: An Evolving ParadigmMarya D Zilberbeg, Imran Khan, Andrew F ShorrAntibiotics (Basel, Switzerland)|February 23, 2024
Bloodstream Infection in the Intensive Care Unit: Evolving Epidemiology and MicrobiologyCarly Munro, Marya D Zilberberg, Andrew F ShorrPageof 26